1. Mattoo, S. and Cherry, J.D., Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies, Clin. Microbiol. Rev., 2005, vol. 18, no. 2, pp. 326–382.
2. Wood, N. and McIntyre, P., Pertussis: review of epidemiology, diagnosis, management and prevention, Paediatr. Respir. Rev., 2008, vol. 9, no. 3, pp. 201–211.
3. Medkova, A.Yu., Alyapkina, Yu.S., Sinyashina, L.N., et al., Detection of avirulent insertional Bordetella pertussis bvg–mutants in patients with pertussis and with upper respiratory tract infection and in seemingly healthy people, Mol. Genet. Microbiol. Virusol., 2010, vol. 25, no. 4, pp. 167–171.
4. Medkova, A.Yu., Alyapkina, Yu.S., Sinyashina, L.N., et al., The prevalence of subclinical forms of pertussis and analysis of phase states of bacteria Bordetella pertussis, Det. Infekts., 2010, no. 4, pp. 19–22.
5. Wiley, K.E., Zuo, Y., Macartney, K.K., and Mc Intyre, P.B., Sources of pertussis infection in young infants: a review of key evidence informing targeting of the cocoon strategy, Vaccine, 2013, vol. 31, no. 4, pp. 618–625.